View in EDS

Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.

Saved in:
Bibliographic Details
Title: Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Authors: Pitiyarachchi, Omali1 (AUTHOR), Ansell, Peter J.2 (AUTHOR), Coleman, Robert L.3 (AUTHOR), Dinh, Minh H.2 (AUTHOR), Holman, Laura4 (AUTHOR), Leath III, Charles A.5 (AUTHOR), Werner, Theresa6 (AUTHOR), DiSilvestro, Paul7 (AUTHOR), Morgan, Mark8 (AUTHOR), Tew, William9 (AUTHOR), Lee, Christine10 (AUTHOR), Cunningham, Mary11 (AUTHOR), Newton, Meredith12 (AUTHOR), Edraki, Babak13 (AUTHOR), Lim, Peter14 (AUTHOR), Barlin, Joyce15 (AUTHOR), Spirtos, Nicola M.16 (AUTHOR), Tewari, Krishnansu S.17 (AUTHOR), Edelson, Mitchell18 (AUTHOR), Reid, Thomas19 (AUTHOR)
Source: Gynecologic Oncology. Aug2024, Vol. 187, p221-226. 6p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2024.05.021